Bank of Montreal’s Orthofix Medical OFIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-80,036
| Closed | -$1.05M | – | 4220 |
|
|
2023
Q3 | $1.05M | Buy |
80,036
+47,437
| +146% | +$853K | ﹤0.01% | 2034 |
|
|
2023
Q2 | $642K | Buy |
32,599
+1,133
| +4% | +$21.2K | ﹤0.01% | 2423 |
|
|
2023
Q1 | $550K | Buy |
31,466
+4,452
| +16% | +$87.1K | ﹤0.01% | 2406 |
|
|
2022
Q4 | $559K | Sell |
27,014
-253
| -0.9% | -$4.46K | ﹤0.01% | 2539 |
|
|
2022
Q3 | $540 | Sell |
27,267
-24,715
| -48% | -$556K | ﹤0.01% | 2542 |
|
|
2022
Q2 | $1.3K | Buy |
51,982
+22,925
| +79% | +$657K | ﹤0.01% | 2149 |
|
|
2022
Q1 | $968K | Buy |
29,057
+1,957
| +7% | +$62.9K | ﹤0.01% | 2371 |
|
|
2021
Q4 | $847K | Sell |
27,100
-231,073
| -90% | -$7.72M | ﹤0.01% | 2045 |
|
|
2021
Q3 | $10.5M | Buy |
258,173
+220,365
| +583% | +$8.77M | ﹤0.01% | 1267 |
|
|
2021
Q2 | $1.53M | Sell |
37,808
-172,756
| -82% | -$7.3M | ﹤0.01% | 2220 |
|
|
2021
Q1 | $8.88M | Buy |
210,564
+3,244
| +2% | +$143K | 0.01% | 1077 |
|
|
2020
Q4 | $8.89M | Sell |
207,320
-60,729
| -23% | -$2.22M | 0.01% | 1078 |
|
|
2020
Q3 | $8.68M | Buy |
268,049
+20,323
| +8% | +$630K | 0.01% | 918 |
|
|
2020
Q2 | $7.35M | Buy |
247,726
+16,610
| +7% | +$551K | 0.01% | 990 |
|
|
2020
Q1 | $6.16M | Buy |
231,116
+47,612
| +26% | +$1.84M | 0.01% | 895 |
|
|
2019
Q4 | $8.47M | Buy |
183,504
+77,570
| +73% | +$3.65M | 0.01% | 1075 |
|
|
2019
Q3 | $5.62M | Buy |
105,934
+52,214
| +97% | +$2.69M | ﹤0.01% | 1148 |
|
|
2019
Q2 | $2.84M | Sell |
53,720
-2,580
| -5% | -$137K | ﹤0.01% | 1480 |
|
|
2019
Q1 | $3.18M | Sell |
56,300
-1,986
| -3% | -$111K | ﹤0.01% | 1417 |
|
|
2018
Q4 | $3.06M | Buy |
58,286
+13,266
| +29% | +$755K | ﹤0.01% | 1321 |
|
|
2018
Q3 | $2.6M | Buy |
45,020
+10,956
| +32% | +$614K | ﹤0.01% | 1534 |
|
|
2018
Q2 | $1.94M | Sell |
34,064
-15,769
| -32% | -$898K | ﹤0.01% | 1658 |
|
|
2018
Q1 | $2.93M | Buy |
49,833
+469
| +1% | +$26.3K | ﹤0.01% | 1393 |
|
|
2017
Q4 | $2.7M | Buy |
49,364
+32,570
| +194% | +$1.69M | ﹤0.01% | 1441 |
|
|
2017
Q3 | $793K | Buy |
16,794
+15,809
| +1,605% | +$744K | ﹤0.01% | 2080 |
|
|
2017
Q2 | $46K | Sell |
985
-291
| -23% | -$12.1K | ﹤0.01% | 3254 |
|
|
2017
Q1 | $49K | Sell |
1,276
-19,553
| -94% | -$724K | ﹤0.01% | 3089 |
|
|
2016
Q4 | $785K | Sell |
20,829
-81,789
| -80% | -$3.1M | ﹤0.01% | 1977 |
|
|
2016
Q3 | $4.39M | Buy |
102,618
+91,892
| +857% | +$4.1M | ﹤0.01% | 1150 |
|
|
2016
Q2 | $456K | Buy |
10,726
+3,920
| +58% | +$170K | ﹤0.01% | 2145 |
|
|
2016
Q1 | $282K | Hold |
6,806
| – | – | ﹤0.01% | 2287 |
|
|
2015
Q4 | $267K | Buy |
6,806
+1,243
| +22% | +$46.4K | ﹤0.01% | 2260 |
|
|
2015
Q3 | $188K | Buy |
+5,563
| New | +$198K | ﹤0.01% | 2297 |
|
|
2014
Q3 | – | Sell |
-450
| Closed | -$16K | – | 4292 |
|
|
2014
Q2 | $16K | Buy |
+450
| New | +$14.5K | ﹤0.01% | 3684 |
|
|
2014
Q1 | – | Sell |
-400
| Closed | -$9K | – | 4110 |
|
|
2013
Q4 | $9K | Hold |
400
| – | – | ﹤0.01% | 3438 |
|
|
2013
Q3 | $8K | Hold |
400
| – | – | ﹤0.01% | 3484 |
|
|
2013
Q2 | $11K | Buy |
+400
| New | +$12K | ﹤0.01% | 3266 |
|
Other funds holding OFIX
RCMNY
AC
ECM
NM
PCMI
Bank of Montreal's OFIX Position: Q4 2023 in Review
Bank of Montreal sold out of Orthofix Medical (OFIX) in Q4 2023, closing a stake of 80,036 shares — an estimated $1.05M sold.
Bank of Montreal first reported a position in OFIX in Q2 2013 and held it in 37 quarters. The position peaked at $10.5M in Q3 2021. 156 funds tracked by Wall St. Rank hold OFIX as of Q4 2023.
- Bank of Montreal reported no remaining Orthofix Medical position as of Q4 2023 after selling out during the quarter.
- Bank of Montreal sold 80,036 Orthofix Medical shares in Q4 2023, an estimated $1.05M.
- Bank of Montreal first reported a position in Orthofix Medical in Q2 2013 and held it in 37 quarters.
- Bank of Montreal's Orthofix Medical position peaked at $10.5M in Q3 2021.
- 156 funds tracked by Wall St. Rank held Orthofix Medical as of Q4 2023.
Based on Bank of Montreal's 13F filing for Q4 2023, filed 8 Feb 2024.